Shibamoto Y - Search Results

1

Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma.

Iwata H, Tatewaki K, Inoue M, Yokota N, Baba Y, Nomura R, Shibamoto Y, Sato K. Iwata H, et al. Among authors: shibamoto y. J Neurooncol. 2012 Feb;106(3):571-7. doi: 10.1007/s11060-011-0693-3. Epub 2011 Aug 23. J Neurooncol. 2012. PMID: 21861196

2

Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study.

Shibamoto Y, Sasai K, Oya N, Hiraoka M. Shibamoto Y, et al. J Neurooncol. 1999 Apr;42(2):161-7. doi: 10.1023/a:1006106530795. J Neurooncol. 1999. PMID: 10421074 Clinical Trial.

3

Long-term results of radiation therapy for pituitary adenoma.

Kokubo M, Sasai K, Shibamoto Y, Aoki T, Oya N, Mitsumori M, Takahashi JA, Hashimoto N, Hiraoka M. Kokubo M, et al. Among authors: shibamoto y. J Neurooncol. 2000 Mar;47(1):79-84. doi: 10.1023/a:1006450024305. J Neurooncol. 2000. PMID: 10930104

4

Efficacy of conventional radiotherapy for recurrent meningioma.

Kokubo M, Shibamoto Y, Takahashi JA, Sasai K, Oya N, Hashimoto N, Hiraoka M. Kokubo M, et al. Among authors: shibamoto y. J Neurooncol. 2000 May;48(1):51-5. doi: 10.1023/a:1006430102406. J Neurooncol. 2000. PMID: 11026697

5

Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy.

Nemoto K, Shibamoto Y, Ohmagari J, Baba Y, Ebe K, Ariga H, Takai Y, Ouchi A, Sasai K, Shinozaki M, Tsujitani M, Sakaguchi M, Yamada S, Sakamoto K. Nemoto K, et al. Among authors: shibamoto y. Anticancer Drugs. 2001 Jan;12(1):1-6. doi: 10.1097/00001813-200101000-00001. Anticancer Drugs. 2001. PMID: 11272282 Clinical Trial.

6

Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure.

Oya N, Shibamoto Y, Nagata Y, Negoro Y, Hiraoka M. Oya N, et al. Among authors: shibamoto y. J Neurooncol. 2002 Jan;56(1):87-94. doi: 10.1023/a:1014442106111. J Neurooncol. 2002. PMID: 11949831

7

Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame.

Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, Araki N, Mitsumori M, Sasai K, Shibamoto Y, Koga S, Yano S, Hiraoka M. Nagata Y, et al. Among authors: shibamoto y. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1041-6. doi: 10.1016/s0360-3016(01)02731-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11958900

8

Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years.

Shibamoto Y, Tsuchida E, Seki K, Oya N, Hasegawa M, Toda Y, Takemoto M, Sumi M, Hiratsuka J, Oguchi M, Hosono M, Yasuda S, Sougawa M, Kakutoh Y, Hayabuchi N. Shibamoto Y, et al. J Cancer Res Clin Oncol. 2004 Jun;130(6):351-6. doi: 10.1007/s00432-004-0547-x. Epub 2004 Mar 18. J Cancer Res Clin Oncol. 2004. PMID: 15034788

9

CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome.

Ogino H, Shibamoto Y, Takanaka T, Suzuki K, Ishihara S, Yamada T, Sugie C, Nomoto Y, Mimura M. Ogino H, et al. Among authors: shibamoto y. Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):803-8. doi: 10.1016/j.ijrobp.2004.10.026. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936563

10

Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.

Shibamoto Y, Ogino H, Hasegawa M, Suzuki K, Nishio M, Fujii T, Kato E, Ishihara S, Sougawa M, Kenjo M, Kawamura T, Hayabuchi N. Shibamoto Y, et al. Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):809-13. doi: 10.1016/j.ijrobp.2004.12.043. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

594 results

Search Page